Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Asymmetry in scientific method and limits to cross-disciplinary dialogue: toward a shared language and science policy in pharmacogenomics and human disease genetics.

Journal of investigative medicine : the official publication of the American Federation for Clinical Research - 1 Apr 2007

Ozdemir Vural, Williams-Jones Bryn, Graham Janice E, Preskorn Sheldon H, Gripeos Dimitrios, Glatt Stephen J, Friis Robert H, Reist Christopher, Szabo Sandor, Lohr James B, Someya Toshiyuki

Abstract excerpt

Pharmacogenomics is a hybrid field of experimental science at the intersection of human disease genetics and clinical pharmacology sharing applications of the new genomic technologies. But this hybrid field is not yet stable or fully integrated, nor is science policy in pharmacogenomics fully equipped to resolve the challenges of this emerging hybrid field. The disciplines of human disease genetics and clinical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomedical Research
Share to Drug Approval

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetics, Medical

Share to Interdisciplinary Communication

Share to Pharmacogenetics

Share to Public Policy

Share to Research Design

Share to United States

Source

Identifiers

PMID: 17481382
DOI: 10.2310/6650.2007.06042

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Asymmetry in scientific method and limits to cross-disciplinary dialogue: toward a shared language and science policy in pharmacogenomics and human disease genetics.PMID 17481382Read ↗

Applying an equity lens to pharmacogenetic research and translation to under-represented populations.Semantic proximity Read ↗

Diversity In Precision Medicine And Pharmacogenetics: Methodological And Conceptual Considerations For Broadening ParticipationSemantic proximity Read ↗

[Ethics on genetic research (1). Pharmacogenetic studies].Semantic proximity Read ↗

Ethics and policy perspectives on personalized medicine in the post-genomic era.Semantic proximity Read ↗

To replicate or not to replicate: the case of pharmacogenetic studies: Have pharmacogenomics failed, or do they just need larger-scale evidence and more replication?Semantic proximity Read ↗

Bioethical considerations for human nutrigenomics.Semantic proximity Read ↗

Race and Pharmacogenomics—Personalized Medicine or Misguided Practice?Semantic proximity Read ↗

Practice and public policy in the era of gene-environment interactions.Semantic proximity Read ↗

To replicate or not to replicate: the case of pharmacogenetic studies: Establishing validity of pharmacogenomic findings: from replication to triangulation.Semantic proximity Read ↗

Pharmacogenomics research involving racial classification: qualitative research findings on researchers' views, perceptions and attitudes towards socioethical responsibilities.Semantic proximity Read ↗

Multigenic Control of Drug Response and Regulatory Decision-Making in Pharmacogenomics: The Need for an Upper-Bound Estimate of Genetic Contributions.Semantic proximity Read ↗

Precision medicine at the crossroads.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.